Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. (CMMB) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 29 transactions totaling $2.7M, demonstrating a bearish sentiment with -$2.3M in net insider flow. The most recent transaction on Jan 3, 2023 involved a sale of 7,700 shares valued at $38.7K.
CMMB Insider Activity Summary
Who Is Buying CMMB Stock?
No significant insider buying has been recorded for CMMB in the recent period.
Who Is Selling CMMB Stock?
No significant insider selling has been recorded for CMMB in the recent period.
Is Chemomab Therapeutics Ltd. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CMMB is bearish with an Insider Alignment Score of 7/100 and a net flow of -$2.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CMMB Frequently Asked Questions
Understanding CMMB Insider Activity
Insider trading at Chemomab Therapeutics Ltd. (CMMB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading CMMB stock, having executed 29 transactions in the past 90 days. The most active insider is Israel Gp Ltd. Orbimed (Executive), who has made 1 transactions totaling $5.0M.
Related Tools
Track Chemomab Therapeutics Ltd. Insider Activity
Get notified when executives and directors at CMMB file new Form 4 transactions